EA200600485A1 - Способ получения производных 2-оксо-1-пирролидина - Google Patents
Способ получения производных 2-оксо-1-пирролидинаInfo
- Publication number
- EA200600485A1 EA200600485A1 EA200600485A EA200600485A EA200600485A1 EA 200600485 A1 EA200600485 A1 EA 200600485A1 EA 200600485 A EA200600485 A EA 200600485A EA 200600485 A EA200600485 A EA 200600485A EA 200600485 A1 EA200600485 A1 EA 200600485A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- oxo
- producing
- pyrrolidine derivatives
- pyrrolidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
Abstract
Предложен новый способ получения производных 2-оксо-1-пирролидина общей формулы (I)в которой заместители являются такими, как определено в описании настоящего изобретения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03021534 | 2003-09-24 | ||
PCT/EP2004/010212 WO2005028435A1 (en) | 2003-09-24 | 2004-09-13 | Process for preparing 2-oxo-1-pyrrolidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600485A1 true EA200600485A1 (ru) | 2007-02-27 |
EA010306B1 EA010306B1 (ru) | 2008-08-29 |
Family
ID=34354424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600485A EA010306B1 (ru) | 2003-09-24 | 2004-09-13 | Способ получения производных 2-оксо-1-пирролидина |
Country Status (15)
Country | Link |
---|---|
US (1) | US7629474B2 (ru) |
EP (1) | EP1667967B1 (ru) |
JP (1) | JP4658937B2 (ru) |
KR (1) | KR101124098B1 (ru) |
CN (1) | CN1882535B (ru) |
BR (1) | BRPI0414436A (ru) |
CA (1) | CA2538938C (ru) |
DK (1) | DK1667967T3 (ru) |
EA (1) | EA010306B1 (ru) |
ES (1) | ES2390455T3 (ru) |
HK (1) | HK1094702A1 (ru) |
IL (1) | IL174029A (ru) |
PL (1) | PL1667967T3 (ru) |
WO (1) | WO2005028435A1 (ru) |
ZA (1) | ZA200601970B (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103696A2 (en) * | 2005-04-01 | 2006-10-05 | Rubamin Laboratories Limited | Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives |
EA016518B1 (ru) * | 2005-09-15 | 2012-05-30 | Юсб Фарма, С.А. | 4-замещенные пирролидин-2-оны и их применение |
WO2007065634A1 (en) * | 2005-12-07 | 2007-06-14 | Ucb Pharma, S.A. | 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses |
WO2016075082A1 (en) | 2014-11-10 | 2016-05-19 | Sandoz Ag | Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam |
MX2017015133A (es) | 2015-05-25 | 2018-08-01 | Suzhou Pengxu Pharmatech Co Ltd | Procesos para producir brivaracetam. |
WO2017076737A1 (en) | 2015-11-03 | 2017-05-11 | Ucb Biopharma Sprl | Continuous process for preparing brivaracetam |
SI3371150T1 (sl) | 2015-11-03 | 2021-11-30 | UCB Biopharma SRL | Postopek za pripravo brivaracetama |
CN105646319B (zh) * | 2015-12-30 | 2018-05-18 | 佛山市隆信医药科技有限公司 | 一种布瓦西坦的制备方法 |
CN107513031B (zh) * | 2016-06-16 | 2022-08-02 | 上海医药集团股份有限公司 | 一种2-氧代-1-吡咯烷手性衍生物的制备方法 |
CN108218757A (zh) * | 2016-12-14 | 2018-06-29 | 上海医药集团股份有限公司 | 对2-(4-丙基吡咯烷-2-酮)-丁酰胺非对映异构体的拆分方法 |
CN106748950B (zh) * | 2017-01-13 | 2019-09-03 | 成都美域高制药有限公司 | 一种布瓦西坦及其中间体的制备方法 |
CN108658831B (zh) * | 2017-03-30 | 2021-11-05 | 江苏豪森药业集团有限公司 | 2-氧代-1-吡咯烷衍生物或其盐的制备方法 |
CN107793342A (zh) * | 2017-10-19 | 2018-03-13 | 丽珠集团新北江制药股份有限公司 | 一种布瓦西坦的制备方法 |
CN108548873A (zh) * | 2018-03-20 | 2018-09-18 | 丽珠集团新北江制药股份有限公司 | 一种布瓦西坦中间体异构体的检测方法 |
CN108929289B (zh) * | 2018-06-19 | 2022-01-04 | 上海博氏医药科技有限公司 | 一种用于制备布瓦西坦的中间体化合物及其制备方法和用途 |
CN110615744B (zh) | 2018-06-20 | 2023-01-06 | 上海朴颐化学科技有限公司 | 一种布瓦西坦中间体及其制备方法 |
CN111333563B (zh) | 2018-12-19 | 2023-11-07 | 上海科胜药物研发有限公司 | 一种布瓦西坦中间体的制备方法 |
CN111892526A (zh) * | 2019-05-06 | 2020-11-06 | 北京万全德众医药生物技术有限公司 | 一种布瓦西坦的新制备方法 |
EP4144724A4 (en) | 2020-04-30 | 2023-03-15 | Shanghai Syncores Technologies Inc. Ltd. | BRIVARACETAM AND PROCESS FOR MAKING AN INTERMEDIATE THEREOF |
WO2023100110A1 (en) | 2021-12-02 | 2023-06-08 | Macfarlan Smith Limited | Process for preparing brivaracetam |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB8827389D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US20040092575A1 (en) * | 2001-03-22 | 2004-05-13 | Jacques Peuvot | Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
WO2002094787A1 (en) * | 2001-05-23 | 2002-11-28 | Ucb, S.A. | 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
IL160045A0 (en) * | 2001-08-10 | 2004-06-20 | Ucb Sa | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
-
2004
- 2004-09-13 PL PL04765134T patent/PL1667967T3/pl unknown
- 2004-09-13 ES ES04765134T patent/ES2390455T3/es active Active
- 2004-09-13 EP EP04765134A patent/EP1667967B1/en active Active
- 2004-09-13 DK DK04765134.4T patent/DK1667967T3/da active
- 2004-09-13 US US10/572,579 patent/US7629474B2/en active Active
- 2004-09-13 KR KR1020067005793A patent/KR101124098B1/ko active IP Right Grant
- 2004-09-13 CN CN200480033998XA patent/CN1882535B/zh active Active
- 2004-09-13 WO PCT/EP2004/010212 patent/WO2005028435A1/en active Application Filing
- 2004-09-13 ZA ZA200601970A patent/ZA200601970B/en unknown
- 2004-09-13 BR BRPI0414436-8A patent/BRPI0414436A/pt not_active Application Discontinuation
- 2004-09-13 JP JP2006527306A patent/JP4658937B2/ja active Active
- 2004-09-13 EA EA200600485A patent/EA010306B1/ru not_active IP Right Cessation
- 2004-09-13 CA CA2538938A patent/CA2538938C/en active Active
-
2006
- 2006-03-01 IL IL174029A patent/IL174029A/en active IP Right Grant
-
2007
- 2007-02-16 HK HK07101917.1A patent/HK1094702A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1882535B (zh) | 2011-05-11 |
JP2007515387A (ja) | 2007-06-14 |
PL1667967T3 (pl) | 2012-11-30 |
IL174029A (en) | 2012-06-28 |
CA2538938C (en) | 2011-08-09 |
EP1667967A1 (en) | 2006-06-14 |
JP4658937B2 (ja) | 2011-03-23 |
EP1667967B1 (en) | 2012-08-01 |
KR101124098B1 (ko) | 2012-03-21 |
AU2004274157A1 (en) | 2005-03-31 |
ZA200601970B (en) | 2007-05-30 |
EA010306B1 (ru) | 2008-08-29 |
CA2538938A1 (en) | 2005-03-31 |
US7629474B2 (en) | 2009-12-08 |
IL174029A0 (en) | 2006-08-01 |
ES2390455T3 (es) | 2012-11-13 |
WO2005028435A1 (en) | 2005-03-31 |
US20070100150A1 (en) | 2007-05-03 |
KR20060121889A (ko) | 2006-11-29 |
HK1094702A1 (ru) | 2007-04-04 |
BRPI0414436A (pt) | 2006-11-14 |
CN1882535A (zh) | 2006-12-20 |
DK1667967T3 (da) | 2012-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600485A1 (ru) | Способ получения производных 2-оксо-1-пирролидина | |
SG158848A1 (en) | Method for producing annelated piperazin-2-one derivatives and intermediates of said method | |
EA200602169A1 (ru) | Способ получения производных 2-оксо-1-пирролидина внутримолекулярным аллилированием | |
EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
HK1088597A1 (en) | Method for the production of substituted 3-aryl-butyl amine compounds | |
HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
EA200800549A1 (ru) | Региоселективный способ получения бензимидазолтиофенов | |
WO2006021379A8 (de) | Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
EA200600197A1 (ru) | Получение производных соединения 1,3-дифенилпроп-2-ен-1-он | |
MXPA05011962A (es) | Oxiarenos substituidos. | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
EA200700766A1 (ru) | Способ получения производных [1,4,5]-оксадиазепина | |
EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
PL1893589T3 (pl) | PODSTAWIONE POCHODNE N-BENZO[D]IZOKSAZOL-3-ILOAMINY JAKO INHIBITORY RECEPTORÓW mGluR5, SEROTONINY (5-HT) I NORADRENALINY I ICH ZASTOSOWANIE DO WYTWARZANIA ŚRODKÓW LECZNICZYCH | |
ATE471312T1 (de) | Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung | |
ATE466003T1 (de) | Herstellung von 2-aminothiazol-5- carbonsäurederivaten | |
EA200400876A1 (ru) | Способ получения производных толуола | |
ATE318815T1 (de) | Verfahren zur herstellung von enantiomeren von indol-2,3-dion-3-oximderivaten | |
WO2004096828A3 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes | |
ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
MXPA05011169A (es) | Metodo para sintetizar derivados de 5-cloro-1-aril-4 -(4, 5-diciano- 1h-imidazol-2-il)- 3-alquil -1h-pirazola. | |
ATE537160T1 (de) | Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat | |
ATE466847T1 (de) | Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment |